Finally, 6-acylamino-2-aminoquinolines were identified as potent Melanin-Concentrating Hormone 1 Receptor (MCH1R) antagonists, a potential target to tackle obesity [14]. Here, MCHR1 is linked to obesity due to melanocortin 4 receptor deficiency.